title: Targeting mutant p53 in human tumors.
authors.affiliation: Vanderbilt-Ingram Cancer Center, 652 Preston Research Building, Nashville, TN 37232, USA. j.pietenpol@vanderbilt.edu
authors.forename: Brian D
authors.initials: BD
authors.lastname: Lehmann
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Pietenpol
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy / Q000379:methods; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D061214:Patient Safety; D011812:Quinuclidines / Q000627:therapeutic use*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D015398:Signal Transduction / Q000187:drug effects; D016019:Survival Analysis; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000187:drug effects* / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D011812:Quinuclidines; D016159:Tumor Suppressor Protein p53; C533410:eprenetapopt